![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1625, 2008-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emtricitabine/Tenofovir Disoproxil Fumarate
Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emtricitabine/Tenofovir Disoproxil Fumarate
By Toni M. Dando Antona J. Wagstaff
Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emtricitabine/tenofovir DF reduces BMD, shows ASSERT
Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emtricitabine/Tenofovir Disoproxil Fumarate: A Viewpoint by Daniel Podzamczer
Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. :